
Keywords: AGE, advanced glycation end products; RAGE, cellular receptor for AGEs; sRAGE, soluble receptor for AGEs; CVD, cardiovascular disease; PCOS, polycystic ovary syndrome; MG, synthetic methylglyoxal; eNOS, endothelial nitric oxidase synthase NOS; NO, nitric